Abstract
RESISTANT PATTERN OF NALIDIXIC ACID AGAINST UROPATHOGENS IN SELECTED AREAS OF DHAKA CITY, BANGLADESH

Mohammad Asaduzzaman*, Apu Alam Miah, Md. Khairul Alam Bhuiyan, Md. Jahangir Alam, Farha Matin Juliana, Nazmul Hossain, Biswajit Das and Runa Asma

ABSTRACT

Treatment of urinary tract infections is becoming more complicated with an increase of the number of resistant strains to antibiotics and prevalence of antibiotic resistance mechanisms. Our aim was to assess the susceptible pattern of Nalidixic Acid which is a synthetic drug of Quinolone antibiotic against uropathogens which cased Urinary Tract Infections. A total of 9178 urine samples were collected in 2016 (January-December) and out of which 890 (9.70%) were bacteriologically positive. Among the isolated uropathogens, 94.1% were gram negative and 5.9% gram positive organism. Male were found more prone to get UTI under 10 years and between 51-80 years of age and females were more affected in 10 to 50 years and over 80 years of age group. E. coli was the most prevalent (83.9%) isolate followed by Klebsiella spp. (7.1%), Staphylococcus aureus (3.1%), Enterococci spp. (2.6%), Pseudomonas spp. (2.2%), Proteus spp. (0.8%) and Staphylococcus saprophyticus (0.2%). The most predominant sensitive organisms to Nalidixic Acid were Klebsiella spp. (male 31.3% and female 40.4%) and resistant organisms Pseudomonas spp. (100%) and Proteus spp. (100%) in both male and female found. Around 87.6% male and 76.8% female were found resistant to E. coli.

Keywords: Nalidixic Acid, Quinolone, UTI, Resistance, Uropathogen.


[Full Text Article]   [Download Certificate]

Indexing

Best Article Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: OCTOBER ISSUE PUBLISHED

    OCTOBER 2026 Issue has been successfully launched on 1 OCTOBER 2026.

  • EJBPS: New Impact Factor 2026

    EJBPS Impact Factor has been Increased from  7.482 to 8.181 for Year 2026.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

Google Scholar Index Copernicus Indian Science Publications Urlich's Periodicals Directory, Proquest, UK (In Process) Research Bible, Fuchu, Tokyo. JAPAN UDLedge Science Citation Index International Society for Research activity (ISRA) Scientific Indexing Services (SIS) InfoBase Index (In Process) SJIF Impact Factor Scholar Article Impact Factor, SAIF Universal Impact Factor CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Global Impact Factor (GIF) (0.377) IP Indexing (IP Value 3.77) Web of Science Group (Under Process) Directory of Research Journals Indexing Scope Database Academia Academia Doi-Digital Online Identifier Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT